Sophiris Bio (SPHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,434 | -17,209 | -8,460 | -11,149 | -5,711 |
| Depreciation Amortization | 269 | 228 | 123 | 581 | 448 |
| Accounts receivable | 30 | 33 | -5 | 23 | 36 |
| Accounts payable and accrued liabilities | 2,422 | 2,196 | 2,947 | -305 | -174 |
| Other Working Capital | 3,693 | 2,449 | 1,605 | -3,354 | -4,295 |
| Other Operating Activity | -774 | -1,111 | -2,344 | 998 | 874 |
| Operating Cash Flow | $-19,794 | $-13,414 | $-6,134 | $-13,206 | $-8,822 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -3 | N/A | -2 | -3 |
| Purchase Of Investment | -17,992 | -11,496 | -3,799 | -33,320 | N/A |
| Sale Of Investment | 38,301 | 30,401 | 15,450 | N/A | N/A |
| Investing Cash Flow | $20,302 | $18,902 | $11,651 | $-33,322 | $-3 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,362 | 2,362 | N/A | N/A | N/A |
| Debt Repayment | -3,361 | -3,361 | -1,661 | -5,524 | -3,903 |
| Common Stock Issued | 1,891 | 1,984 | N/A | 57,253 | 57,816 |
| Other Financing Activity | -53 | -53 | -53 | 0 | 0 |
| Financing Cash Flow | $839 | $932 | $-1,714 | $51,729 | $53,913 |
| Exchange Rate Effect | -12 | -4 | -10 | -83 | -70 |
| Beginning Cash Position | 14,839 | 14,839 | 14,839 | 9,721 | 9,721 |
| End Cash Position | 16,174 | 21,255 | 18,632 | 14,839 | 54,739 |
| Net Cash Flow | $1,335 | $6,416 | $3,793 | $5,118 | $45,018 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,794 | -13,414 | -6,134 | -13,206 | -8,822 |
| Capital Expenditure | -7 | -3 | N/A | -3 | -3 |
| Free Cash Flow | -19,801 | -13,417 | -6,134 | -13,209 | -8,825 |